Fund Details
Pace Ventures
Overview
Investment portfolio
16rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Ternary Therapeutics | Mar 2026Participated | $5 MSeed | |
Neurable | Dec 2025Participated | $35 MSeries A | |
Metri Bio | Dec 2025Participated | $5 MSeed | |
Cellbyte | Nov 2025Participated | $3 MSeed | |
ChemFinity Technologies | Aug 2025Participated | $7 MSeed | |
Bitfount | Jul 2025Participated | $8 MSeries A | |
Vema Hydrogen | Feb 2025Participated | $13 MSeed | |
Centauri Therapeutics | Nov 2024Led | $1 MGrant | |
Glox Therapeutics | Nov 2024Led | $1 MGrant | |
ArrePath | Nov 2024Led | $1 MGrant | |
Dunia Innovation | Oct 2024Participated | $12 MOther Equity | |
Dunia | Oct 2024Participated | $11 MOther Equity | |
Ternary Therapeutics | Mar 2026Participated | $5 MSeed | |
Neurable | Dec 2025Participated | $35 MSeries A | |
Metri Bio | Dec 2025Participated | $5 MSeed | |
Cellbyte | Nov 2025Participated | $3 MSeed | |
ChemFinity Technologies | Aug 2025Participated | $7 MSeed | |
Bitfount | Jul 2025Participated | $8 MSeries A | |
Vema Hydrogen | Feb 2025Participated | $13 MSeed | |
Centauri Therapeutics | Nov 2024Led | $1 MGrant | |
Glox Therapeutics | Nov 2024Led | $1 MGrant | |
ArrePath | Nov 2024Led | $1 MGrant | |
Dunia Innovation | Oct 2024Participated | $12 MOther Equity | |
Dunia | Oct 2024Participated | $11 MOther Equity |
16 Items
16
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 2 | 6 |
| Series A | 0 | 2 |
| Other Equity | 0 | 3 |
| Grant | 3 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 4 |
| Nov '24 | 3 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 1 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 1 |
| Aug '25 | 1 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 1 |
| Dec '25 | 2 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 7 |
| Space & Frontier Tech | 5 |
| AI & Machine Learning | 4 |
| Networks, Cloud & Communication | 2 |
| AR/VR | 2 |
| Professional Services | 2 |
| Clean Energy & Sustainability | 2 |
| Data, Analytics & IT | 2 |
| Enterprise Software | 1 |
| Manufacturing | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 7 |
| $5M-$10M | 4 |
| $10M-$25M | 4 |
| $25M-$50M | 1 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 8 |
| Europe | 7 |
| 12489 | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Anglo American | 2 |
| Deep Science Ventures | 2 |
| EIC Fund | 2 |
| Elaia | 2 |
| Kindred Capital | 2 |
| Redalpine | 2 |
| Ahren Innovation Capital | 1 |
| Astanor Ventures | 1 |
| At One Ventures | 1 |
| Climate Capital | 1 |
| Closed Loop Partners | 1 |
| Collaborative Fund | 1 |
| Corundum Systems Biology | 1 |
| Daphni | 1 |
| Extantia | 1 |
| Foresight Group | 1 |
| Frontline Ventures | 1 |
| GC Ventures | 1 |
| Gigascale Capital | 1 |
| Grantham Foundation | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 5 | 31% |
| Participating | 11 | 69% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 60% |
| Co-led | 2 | 40% |
Team
Marius Swart
Managing Partner